Diethylstilbestrol (DES) was etiologically linked to clear cell adenocarcinoma of the vagina in 1971. This article reviews on-going research and emerging information relevant to DES-related health ...

A study of daughters of women given diethylstilbestrol, synthetic estrogen, during pregnancy has found that exposure to the drug while in the womb is associated with many reproductive problems and an ...

Health Secretary Wes Streeting to meet those affected by diethylstilbestrol (DES) given to pregnant women from up to 1970s in ...

We used Cox regression analyses to assess mortality outcomes in a combined cohort of 7675 women who received diethylstilbestrol (DES) through clinical trial participation or prenatal care. In the ...

Daughters of women who took the drug diethylstilbestrol (DES) during pregnancy may be at a greater risk for breast cancer, say researchers from the Boston University School of Public Health. DES was ...

Outcome of older patients with breast cancer with brain metastases. Background: Blocking estrogen receptor or production is standard of care for hormone receptor positive advanced breast cancer ...

Four decades after doctors realized that a drug called DES – used to prevent pregnancy complications – had devastating consequences for babies, a new study finds those effects may be reverberating ...

Wes Streeting is being urged to launch a public inquiry into a miscarriage drug which has “ruined and devastated” the lives of countless women.

Victims to call for inquiry into ‘scandal’ of cancer-linked pregnancy drug - ...

Plus, everything you need to know about the drug and side-effects of exposure HUNDREDS of birth defect victims will campaign for justice after their families were harmed by a drug given to pregnant ...

Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with ...

Barbara Hammes, CNM, MS, is a clinical associate professor at the University of Wisconsin-Madison, School of Nursing, Women's Health NP Program. Cynthia J. Laitman, PhD, holds an appointment in the ...